The Ophthalmology Contract Research Organization for Innovators
An End-to-End Partner to Accelerate Your Visionary Device from Concept to Clinical Reality.
The Only Ophthalmology Innovation Contract Research Organization (iCRO) to Conquer the Market Hurdles
Bringing a novel ophthalmic device to market requires navigating a series of significant and interconnected hurdles.

01
Gaining market approval is a primary challenge. High-risk devices requiring Premarket Approval (PMA) face an intensive process, with an average cost of $94 million spent on FDA-required activities alone.
02
Demonstrating safety and efficacy is paramount. A single medical device clinical trial can cost between $5 and $10 million and often requires years of follow-up to prove long-term outcomes.
03
The adoption of advanced technology is limited by a growing physician shortage. By 2035, the U.S. is projected to see a 12% decrease in ophthalmologists while demand surges by 24%.
The Solution
Integrated Ophthalmology Contract Research Organization for Innovation
From initial market insight to final clinical validation, we provide the integrated expertise to accelerate your path to market.
Ensure market success by designing what clinicians and patients actually need
Our teams gather first-hand insights from ophthalmologists, surgical support staff, and patients to define the critical user needs that drive successful product design and development.

Build a durable competitive advantage in the crowded ophthalmology market
We deliver comprehensive market assessments, pricing analyses, and reimbursement strategies to create a clear, data-driven roadmap for commercial success and investor confidence.

Strategically navigate complex global regulatory landscapes
With a 96% FDA submission clearance rate, our regulatory experts develop the least-burdensome strategy for FDA and EU MDR approvals.

Custom anatomical testing models to de-risk development
Custom test models that simulate clinical condition ensures your device performs as intended with the correct evaluation to guide development or use for design verification.

Traceable, high-quality builds from prototype to human trial
We provide controlled manufacturing for your devices in our ISO Class 8 cleanrooms and BSL-2 biohazard lab spaces, ensuring they are ready for preclinical studies and clinical use.

Generate critical safety and performance data with studies designed for clinical relevance
Support with non-GLP, GLP, preclinical training, and histology services for your ophthalmic device. We collaborate directly with consulting ophthalmologists to ensure our preclinical study designs will deliver the most meaningful and translatable outcomes for your specific device.

Execute complex ophthalmic trials designed for successful submission and market adoption
Our global, device-focused CRO excels at managing the unique challenges of ophthalmology trials—from long-term patient follow-up to generating the health economic evidence required for reimbursement.

The Ophthalmic iCRO: Your Integrated Ophthalmology Contract Research Organization
Veranex reimagined what it truly takes to bring breakthrough technologies to life and integrated eight essential disciplines under one roof.
Our Depth of Experience Across Ophthalmic Medical Devices
From retinal implants to advanced drug delivery, our teams have partnered on some of the industry's most complex challenges.

Ophthalmic Therapy Segment: Retinal Disease / Vision Restoration
- Wearable Vision System (External Glasses + Implant)
- We have developed the external smart glasses component and conducted the human factors research for a complex system designed to treat blindness caused by retinitis pigmentosa.

Ophthalmic Therapy Segment: Glaucoma / Minimally Invasive Glaucoma Surgery (MIGS)
- Surgical Implantation Device
- We engineered a unique, ergonomic "pencil grip" implantation device for placing intraocular stents, prioritizing the exceptional control and safety required for delicate glaucoma surgery.

Ophthalmic Therapy Segment: Advanced Drug Delivery
- Microdosing Drug Delivery Platform
- We developed a platform drug delivery technology capable of administering a precise micro-dose to the cornea faster than the human blink reflex, suitable for treating conditions like childhood myopia and macular edema.

Ophthalmic Therapy Segment: Cataract Surgery
- Surgical Implantation Tool
- Our teams have engineered precision intraocular lens (IOL) insertion tools to improve the safety and efficiency of cataract procedures.

Ophthalmic Therapy Segment: Neurological Vision / Vision Restoration
- Human Factors & Imaging Analysis
- We have conducted extensive human factors research and imaging analysis to guide the precise surgical placement of novel visual cortex implants.

Ophthalmic Therapy Segment: Surgical Training & Preclinical Research
- Preclinical Surgical Models & Physician Training
- We have deep experience developing preclinical surgical models for conditions like glaucoma and keratoconjunctivitis. We facilitate physician training for complex procedures such as retinal device implantation and subretinal drug delivery, utilizing our state-of-the-art equipment, including a Leica M820 surgical microscope and a Stellaris vitrectomy machine.

Ophthalmic Therapy Segment: Cataract and Refractive Surgery
- Surgical Platforms & Digital Health Integration
- We have extensive experience providing market access, health economics (time and motion studies), and commercial strategy for market-leading surgical suites. This includes femtosecond laser platforms, 3D visualization systems, and the digital health software that connects them to optimize clinical workflow.

Ophthalmic Therapy Segment: Diagnostics & Surgical Planning
- Biometers & Diagnostic Platforms
- We have supported diagnostic platforms with clinical research, reimbursement strategies, and the development of health economic models and value communication tools to demonstrate their impact on practice efficiency.

Ophthalmic Therapy Segment: Retinal Disease & Glaucoma
- Advanced IOLs, Drug-Eluting Technologies, & Cell Therapies
- Our work includes developing reimbursement landscapes and payer value propositions for a wide range of advanced technologies, including drug-eluting IOLs, surgical devices for AMD, glaucoma drainage devices, and novel cell therapies for both front and back-of-the-eye applications.

Ophthalmic Therapy Segment: Diagnostics & General Eye Care
- Diagnostic & Refractometry Devices
- For manufacturers of high-quality diagnostic devices, we have provided comprehensive regulatory and quality support, including 510(k) submissions, QMS updates, and cleanroom and sterilization validation.

Ophthalmic Therapy Segment: Surgical Assistance
- Assistive Surgical Robotics
- We have partnered with pioneers in ophthalmic robotics, providing crucial regulatory strategy assessments and guidance for FDA pre-submission meetings to support the development of their revolutionary platforms.

Ophthalmic Therapy Segment: Diagnostics & Digital Health
- AI-Powered Remote Retinal Imaging
- We have provided US FDA regulatory assessment support for a de novo digital health platform that uses AI and remote retinal imaging to screen for various disease states.

Ophthalmic Therapy Segment: Retinal Disease
- Advanced Drug Delivery Systems
- For companies specializing in nanotechnology and microelectromechanical systems for drug delivery to the retina, we have provided critical quality support, including Design History File (DHF) updates and risk management.
The Ophthalmology Contract Research Organization That Will Turn Vision into Velocity.
Navigating the complex challenges from early design planning through clinical trials.



